Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 12/06/22 EST

179.00UNCH (UNCH)

Volume

3,457,212

52 week range

115.03 - 321.30

Open172.31
Day High180.38
Day Low171.85
Prev Close179.00
52 Week High321.30
52 Week High Date12/20/21
52 Week Low115.03
52 Week Low Date09/29/22

Key Stats

Market Cap68.768B
Shares Out384.18M
10 Day Average Volume3.17M
Dividend-
Dividend Yield-
Beta1.74
YTD % Change-29.52

KEY STATS

Open172.31
Day High180.38
Day Low171.85
Prev Close179.00
52 Week High321.30
52 Week High Date12/20/21
52 Week Low115.03
52 Week Low Date09/29/22
Market Cap68.768B
Shares Out384.18M
10 Day Average Volume3.17M
Dividend-
Dividend Yield-
Beta1.74
YTD % Change-29.52

RATIOS/PROFITABILITY

EPS (TTM)27.65
P/E (TTM)6.47
Fwd P/E (NTM)22.83
EBITDA (TTM)13.596B
ROE (TTM)83.69%
Revenue (TTM)21.39B
Gross Margin (TTM)79.20%
Net Margin (TTM)55.00%
Debt To Equity (MRQ)6.37%

EVENTS

Earnings Date02/22/2023(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Moderna Inc

Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting historyDecember 6, 2022CNBC.com
This week's best performers include several retail stocks, one exchange operatorNovember 18, 2022CNBC.com
Pfizer says omicron booster better against new subvariants than old shotsNovember 18, 2022CNBC.com
These biotech stocks look cheap — and analysts give 2 more than 100% upsideNovember 15, 2022CNBC.com
Final Trades: Nucor, Moderna, Palto Alto & moreNovember 14, 2022CNBC.com

Content From Our Affiliates

MRNA, BIIB, or IQV: Which Biotech Stock Earns the Street’s “Strong Buy” Rating?December 1, 2022TipRanks
Moderna appoints David Jimenez as general manager, U.S.November 17, 2022TipRanks
Moderna price target raised to $182 from $160 at BofANovember 15, 2022TipRanks
Moderna says bivalent booster shows superiority against omicron variantsNovember 14, 2022TipRanks
Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Genmab (GMAB) and Adaptimmune Therapeutics (ADAP)November 14, 2022TipRanks

Profile

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...

Noubar Afeyan Ph.D.

Non-Executive Independent Chairman of the Board, Co-Founder

Stephane Bancel

Chief Executive Officer, Director

Stephen Hoge M.D.

President

James Mock

Chief Financial Officer

Address

200 Technology Sq

Cambridge, MA

02139-3578

United States

https://www.modernatx.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
BNTX BioNTech SE	162.63	UNCH	UNCH
REGN Regeneron Pharmaceuticals Inc	764.27	UNCH	UNCH
BIIB Biogen Inc	292.15	UNCH	UNCH
ILMN Illumina Inc	208.52	UNCH	UNCH
GMAB Genmab A/S	45.72	UNCH	UNCH